Cosmecca Korea Co Ltd
KOSDAQ:241710
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
24 900
90 500
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Cosmecca Korea Co Ltd
Cash & Cash Equivalents
Cosmecca Korea Co Ltd
Cash & Cash Equivalents Peer Comparison
090430
002790
192820
051900
161890
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cosmecca Korea Co Ltd
KOSDAQ:241710
|
Cash & Cash Equivalents
₩35.8B
|
CAGR 3-Years
30%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Cash & Cash Equivalents
₩506.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
3%
|
|
|
Amorepacific Group
KRX:002790
|
Cash & Cash Equivalents
₩629B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
4%
|
|
|
Cosmax Inc
KRX:192820
|
Cash & Cash Equivalents
₩307.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Cash & Cash Equivalents
₩501.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Cash & Cash Equivalents
₩197.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
30%
|
See Also
What is Cosmecca Korea Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
35.8B
KRW
Based on the financial report for Jun 30, 2024, Cosmecca Korea Co Ltd's Cash & Cash Equivalents amounts to 35.8B KRW.
What is Cosmecca Korea Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
23%
Over the last year, the Cash & Cash Equivalents growth was 27%. The average annual Cash & Cash Equivalents growth rates for Cosmecca Korea Co Ltd have been 30% over the past three years , 23% over the past five years .
You don't have any saved screeners yet
